Chemoprevention options for BRCA1 and BRCA2 mutation carriers.

Abstract excerpt

BRCA1 and BRCA2 breast cancer predisposition gene mutation carriers are at markedly increased risk of breast and other cancers. The consideration of chemopreventative options will depend on the cancer site and age-specific penetrance curve. Most chemoprevention studies to date have investigated the role of endocrine intervention in women at increased risk of breast cancer, and study results are conflicting. At...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticarcinogenic Agents
• Share to BRCA2 Protein
• Share to Breast Neoplasms, Male